Journal
CURRENT PHARMACEUTICAL BIOTECHNOLOGY
Volume 12, Issue 1, Pages 54-67Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/138920111793937916
Keywords
Cold; thermoreceptor; menthol; pain; prostate cancer
Funding
- Spanish MICINN [BFU2007-61855, CSD2007-0002]
- Fundacion Marcelino Botin
Ask authors/readers for more resources
Transient receptor potential melastatin 8 (TRPM8) is a non-selective cation channel activated by cold temperature and cooling agents. TRPM8 is expressed in a subpopulation of cold-sensitive sensory neurons, as well as in the male urogenital system. TRPM8 is markedly upregulated in prostate cancer and in other tumors such as breast adenocarcinoma and melanoma. Moreover, recent studies suggest the potential involvement of TRPM8 channels in the pathophysiology of cold nociception and cold allodynia. This has led to a strong interest in the pursuit of novel modulators of TRPM8 channels. This review highlights our current knowledge of TRPM8 pharmacology and modulation mechanisms, detailing structural features important for TRPM8 gating by different agonists, the mechanism of antagonism by different compounds and the potential relevance of TRPM8 for treatment of various pathological conditions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available